Poster presentation “Validity and reliability of a smartwatch single-lead ECG for monitoring QT interval prolongation: an interventional study with moxifloxacin”.
Dr. Peter Schueler, Senior Vice President, Drug Development Services
14:00 Panel Discussion - From Bench to Bedside - Translating Research into Therapies.
Embedded keynote (within the panel discussion) is: 14:10 Keynote: Enabling early decision making - The role of phase 1b: the requirements, the need for well characterised patient cohorts and the power of registries.
